Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments.
Pauley JL, Panetta JC, Crews KR, Pei D, Cheng C, McCormick J, Howard SC, Sandlund JT, Jeha S, Ribeiro R, Rubnitz J, Pui CH, Evans WE, Relling MV.
Pauley JL, et al.
Cancer Chemother Pharmacol. 2013 Aug;72(2):369-78. doi: 10.1007/s00280-013-2206-x. Epub 2013 Jun 13.
Cancer Chemother Pharmacol. 2013.
PMID: 23760811
Free PMC article.